|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1985; 6:983-991 © 1985 by the American College of Cardiology Foundation |
The safety and short-term therapeutic benefit of multilesion percutaneous transluminal coronary angioplasty was assessed in 135 patients, 66 of whom had a minimum of 6 months of follow-up study. Primary success, defined as successful dilation of the most critical lesion or all lesions attempted without major in-hospital complications was obtained in 117 (87%) of the 135 patients. Cardiac complications associated with the procedure were uncommon; prolonged angina occurred in 5% and myocardial infarction in 3%; emergency coronary bypass surgery was performed in 4% of the patients. There were no deaths. Complete revascularization was achieved in 46% of the 117 patients with a primary success. Of the 66 patients eligible for 6 month follow-up, 80% had an uncomplicated course and required no further procedures. Clinical improvement by at least one angina functional class was observed in 90% of the patients. Cardiac events such as the need for a second revascularization procedure were significantly more common in patients who had incomplete versus complete revascularization (35 versus 9%; p = 0.018). Repeat coronary angiography performed an average of 5 months after angioplasty revealed restenosis in 18 of 22 symptomatic patients and 3 of 9 asymptomatic patients. Restenosis occurred at the site of a single dilation in 12 patients, at two sites in 8 patients and at three sites in 1 patient. Thus, multilesion coronary angioplasty is an important therapeutic option for selected patients with multivessel disease and can be performed with relatively low risk. Improvement in angina status can be expected even in patients who have incomplete revascularization.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  E. L. Hannan, M. Racz, D. R. Holmes, S. B. King III, G. Walford, J. A. Ambrose, S. Sharma, S. Katz, L. T. Clark, and R. H. Jones Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era Circulation, May 23, 2006; 113(20): 2406 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zimarino, A. M. Calafiore, and R. De Caterina Complete myocardial revascularization: between myth and reality Eur. Heart J., September 2, 2005; 26(18): 1824 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Rodriguez, J. Baldi, C. F. Pereira, J. Navia, M. R. Alemparte, A. Delacasa, F. Vigo, D. Vogel, W. O'Neill, I. F. Palacios, et al. Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II) J. Am. Coll. Cardiol., August 16, 2005; 46(4): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. B. M. van den Brand, B. J. W. M. Rensing, M.-a. M. Morel, D. P. Foley, V. de Valk, A. Breeman, H. Suryapranata, M. M. P. Haalebos, W. Wijns, F. Wellens, et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial J. Am. Coll. Cardiol., February 20, 2002; 39(4): 559 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.V Patil, E Nikolsky, M Boulos, E Grenadier, and R Beyar Multivessel coronary artery disease: current revascularization strategies Eur. Heart J., July 2, 2001; 22(14): 1183 - 1197. [PDF]
|
|
|
|
 |
|
 R. Scott, E. H. Blackstone, P. M. McCarthy, B. W. Lytle, F. D. Loop, J. A. White, and D. M. Cosgrove Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary arteryLate consequences of incomplete revascularization J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 173 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Kip, M. G. Bourassa, A. K. Jacobs, L. Schwartz, F. Feit, E. L. Alderman, B. H. Weiner, M. B. Weiss, M. A. Kellett Jr, B. L. Sharaf, et al. Influence of Pre-PTCA Strategy and Initial PTCA Result in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI) Circulation, August 31, 1999; 100(9): 910 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Bourassa, K. E. Kip, A. K. Jacobs, R. H. Jones, G. Sopko, A. D. Rosen, B. L. Sharaf, L. Schwartz, B. R. Chaitman, E. L. Alderman, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI) J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1627 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Hamm, J. Reimers, T. Ischinger, H.-J. Rupprecht, J. Berger, W. Bleifeld, and The German Angioplasty Bypass Surgery Investigatio A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease N. Engl. J. Med., October 20, 1994; 331(16): 1037 - 1043. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Johnson and T. Ports Unstable Angina Pectoris: An Interventional Approach to Management J Intensive Care Med, July 1, 1988; 3(4): 202 - 214. [Abstract] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
